- Pressure BioSciences has been making a name for itself as a leader in the development and sale of proprietary intense-pressure delivery systems to the worldwide life sciences field
- PBIO is developing a novel high pressure platform called Ultra-Shear Technology (“UST”) that processes oil-based solutions into water-soluble nanoemulsions that will allow the molecules inside the oil (e.g., CBD, Vitamins) to be more readily absorbed by human biology
- Development of th proprietary new instrument – the BaroShear K45-has been proceeding well since the Company received orders for all of its planned initial build of 12 units
- Pressure BioSciences reported achieving a critical milestone in the production of the BaroDShear K45 units on Oct. 6 with the lock-in of final design specifications for the commercial model and commencement of building the initial “Alpha” model
- The Company states that once the Alpha model is built, tested and approved, an additional 14 ready-for-sale systems will be built (12 for sale) in time to fulfill plans for shipping the contracted BaroShear K45 Nanoemulsification Systems during early 2021
- The sale of the first dozen BaroShear K45 units is expected to generate up to $3 million for Pressure BioSciences’ revenue stream in just the first half of 2021
- Pressure BioSciences expects that the installation of the initial 12 commercial units will propel the sale of significantly more BaroShear K45 units during the second half of 2021 and thereafter
Life sciences technology innovator Pressure BioSciences (OTCQB: PBIO) has achieved another milestone as it nears the initial production of commercial pressure-inducing technology systems expected to revolutionize a wide variety of industries through the nanoemulsification process.
Pressure BioSciences’ proprietary, next-generation Ultra Shear Technology-based BaroShear K45 System is designed to create unique, high-quality nanoemulsions of otherwise poorly soluble oils so that they become more easily absorbed and…
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]
NetworkNewsWire is part of the InvestorBrandNetwork.